Clinical Trial Update: Reversal of Atrial Substrate to Prevent Atrial Fibrillation Cohort Study

View source ↗

Summary

This clinical trial update describes a cohort study aiming to reverse atrial substrate to prevent atrial fibrillation and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Ratika Parkash | Conditions: Atrial Fibrillation, Paroxysmal or Persistent | Status: RECRUITING